Antiparasitics are a group of drugs used to treat illnesses caused by parasites like nematodes, cestodes, trematodes, and infectious protozoa.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V53855 | Anisofolin A | 83529-71-9 | Anisofolin A is a flavonoid that can be extracted from Anisomeles indica. | |
V34988 | Anti-infective agent 4 | 2738381-52-5 | Anti-infective agent 4 (compound 73) is an orally bioactive Trypanosoma cruzi inhibitor (antagonist) with IC50 of 0.016 μM. | |
V34987 | Anti-infective agent 5 | 2738381-47-8 | Anti-infective agent 5 (compound 74) is an orally bioactive Trypanosoma cruzi inhibitor (antagonist) with IC50 of 0.10 μM. | |
V34986 | Anti-infective agent 6 | 2839192-35-5 | Anti-infective agent 6 (compound 28) is an effective anti-infective agent. | |
V78011 | Anti-inflammatory agent 40 | anti~inflammatory agent 40 is a potential and orally bioactive anti-malarial and anti~inflammatory agent. | ||
V54046 | Anti-parasitic agent 3 | 2366983-10-8 | Anti-parasitic agent 3 is an anti-parasitic agent active against drug-resistant parasites. | |
V76297 | Anti-Trypanosoma cruzi agent-1 | 2854299-38-8 | Anti-Trypanosoma cruzi agent-1 (Compd E5) has potent activity against Toxoplasma gondii. | |
V76298 | Anti-Trypanosoma cruzi agent-2 | 2863602-85-9 | Anti-Trypanosoma cruzi agent-1 (Compd 3b) is selective against NINOA trypomastigote (IC50 = 0.51 µM) and INC-5 epimastigote (IC50 = 3.06 µM) trypanosomatids and has potent anti-Toxoplasma activity. | |
V34844 | Anti-Trypanosoma cruzi agent-4 | 10001-31-7 | Anti-Trypanosoma cruzi agent-4 (compound 5c) is an inhibitor (blocker/antagonist) of Trypanosoma cruzi. | |
V79869 | Anticancer agent 140 | anti-cancer compound 140 (Compd 3) is a compound with potential anticancer and antiparasitic effect. | ||
V54131 | Antileishmanial agent-1 | 2454115-43-4 | Antileishmanial agent-1 has activivty against L. | |
V34843 | Antileishmanial agent-13 | 853725-86-7 | Antileishmanial agent-13 is a quinoline-indigo hybrid that works as an anti-leishmanial agent against L. | |
V52412 | Antileishmanial agent-14 | 1638956-72-5 | Antileishmanial agent-14 is a sulfonamide analog with potential activity against Leishmania donovani promastigotes (IC50=4.1 μM). | |
V54070 | Antileishmanial agent-15 | 2934738-38-0 | Antileishmanial agent-15 (compound 13c) is an effective antileishmanial agent. | |
V34841 | Antileishmanial agent-16 | 2934738-41-5 | Antileishmanial agent-16 (compound 14c) is an anti-Leishmania agent. | |
V34842 | Antileishmanial agent-17 | 2934738-40-4 | Antileishmanial agent-17 is a coumarin hybrid compound with anti-Leishmanial activity (IC50 <0.78 μM). | |
V54115 | Antileishmanial agent-18 | 1007567-02-3 | Antileishmanial agent-18 (Compound 1e) is an antileishmanial agent. | |
V79480 | Antileishmanial agent-19 | Antileishmanial agent-19 (Compound F27) is an anti-leishmanial agent with IC50 of 3.39 μM against L.donovani promastigotes. | ||
V54058 | Antileishmanial agent-2 | 2863687-18-5 | Antileishmanial agent-2 displays submicromolar antileishmanial activity (IC50 = 0.29 μM) and a very high selectivity index against mammalian cells. | |
V80377 | Antileishmanial agent-20 | Antileishmanial agent-20 is selective for Leishmania parasites. |